Global Neuroimmunology Drugs Market | Latest Survey Report with Accurate Forecast to 2030

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Neuroimmunology Drugs Market- By Trends, Industry Competition Analysis, Revenue and Forecast to 2030."

Request for Sample Pages:
Neuroimmunology is the study of the interactions between the central nervous system & the immune system of the body. Scientists study these interactions during development, homeostasis, and response to injuries with the primary aim of developing approaches to treat or prevent neuroimmunological diseases.

Get Free Sample Copy of Report :
https://www.insightaceanalytic.com/request-sample/1171

Factors such as the growing cases of neuroimmunological diseases, rising aging population, advancements in neurogenetics, increasing R&D activities among research institutes & pharma companies to innovate new treatment options for neurological disorders, surging patient preference toward cost-effective drug treatments, availability of strong candidates to treat multiple sclerosis & Alzheimer's disease in clinical development are expected to drive the market in the forthcoming years.

In 2019, around 400,000 Americans and 2.5 million people worldwide were diagnosed with multiple sclerosis (Source: NIH). Hence, the growing prevalence of neuroimmunology diseases is likely to boost the demand for neuroimmunology drugs during the estimated timeframe.

However, the high cost of these drugs is anticipated to restrict the market growth during the forecast period.

Geographically, North America is anticipated to witness maximum market share throughout the forecast years (2020-2030), followed by Europe, owing to the rising prevalence of neuroimmunology diseases, the presence of significant market players, and increasing awareness about mental health. Additionally, Asia-Pacific is projected to lead the market in the coming years due to the availability of well-developed healthcare facilities and growing neurology research investments by the government.

Request for ToC/Proposal:
Major market players operating in the neuroimmunology drugs market include AB Science SA (France), Actelion Pharmaceuticals Ltd. (Switzerland), AstronauTx (UK), AZTherapies Inc. (US), Biogen Inc. (US), Celgene Corp. (US), INmune Bio, Inc. (US), Lundbeck (Denmark), F. Hoffmann-La Roche AG (Switzerland), Genetech Inc. (US), Grifols SA (Spain), Tiaki Therapeutics (US), TG Therapeutics Inc. (US), and TauRX Therapeutics Ltd (UK) among others.

Some of the key developments in the market:
In June 2021, Biogen (US) and Eisai Inc. (Japan) launched multiple initiatives to support ADUHELM drug access for all patients with Alzheimer's disease. The U.S FDA approved ADUHELM as the first and only Alzheimer's disease treatment to address a defining pathology of the disease by reducing amyloid-beta plaques in the brain. These initiatives help patients & their families understand the disease, navigate the diagnostic journey, secure culturally competent care, and afford treatment.
In June 2021, European Commission (EC) approved Roche's ENSPRYNG (satralizumab) as the first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD).
In August 2019, AstronauTx received about USD 6.5 million investment from the government-launched Dementia Discovery Fund (DDF) to develop new medicines designed to reset the behavior of astrocytes, crucial support cells in the brain (dementia research).

Curious about this latest version of the report? Obtain Report Details @
https://www.insightaceanalytic.com/report/global-neuroimmunology-drugs-market-/1171

Market Segments
Global Neuroimmunology Drugs Market, by Indication, 2020-2030 (Value US$ Mn)
Alzheimer's disease (AD)
Multiple Sclerosis (MS)
Others

Global Neuroimmunology Drugs Market, by Target Type, 2020-2030 (Value US$ Mn)
Cytokines
Lymphocytes or Molecules Associated with their Activation or Migration
Others

Global Neuroimmunology Drugs Market, by Region, 2020-2030 (Value US$ Mn)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

North America Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
U.S.
Canada

Europe Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
Germany
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
India
China
Japan
South Korea
Australia & New Zealand

Latin America Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
Brazil
Mexico
Rest of Latin America

Middle East & Africa Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
GCC Countries
South Africa
Rest of Middle East & Africa

Why should buy this report:
To receive a comprehensive analysis of the prospects for the global neuroimmunology drugs market
To receive an industry overview and future trends of the neuroimmunology drugs market
To analyze the neuroimmunology drugs market drivers and challenges
To get information on the neuroimmunology drugs market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the neuroimmunology drugs market industry

For More Information @
https://www.insightaceanalytic.com/report/global-neuroimmunology-drugs-market-/1171

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.